Novel JAK1 Inhibitor Reduced Treatment Failures in Active Noninfectious Uveitis
An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, ...
Read more
Tag: Inhibitor
JAK1 Inhibitor Shows ‘Remarkable’ Activity in T-Cell Lymphoma
Treatment with a novel, oral JAK1 tyrosine kinase inhibitor induced rapid and durable responses in patients with relapsed or refractory ...
Read more
JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes
A Janus kinase (JAK) inhibitor helped preserve beta-cell function in people with recent-onset type 1 diabetes, the phase II BANDIT ...
Read more
First AKT Inhibitor Approved for Advanced Breast Cancer
The FDA approved the first-in-class AKT inhibitor capivasertib (Truqap), in combination with fulvestrant, for locally advanced/metastatic hormone receptor (HR)-positive/HER2-negative breast ...
Read more
ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease
PHILADELPHIA -- A low-dose, investigational endothelin A receptor antagonist paired with an SGLT2 inhibitor reduced albuminuria in patients with chronic ...
Read more
The Earth News is an independent English-language daily published Website from all around the World News